High-density lipoprotein level is associated with hemorrhage transformation after ischemic stroke treatment with intravenous thrombolysis: A systematic review and meta-analysis

J Clin Neurosci. 2022 Dec:106:122-127. doi: 10.1016/j.jocn.2022.10.016. Epub 2022 Oct 22.

Abstract

Background: Treatment of acute ischemic stroke (AIS) with intravenous tissue-type plasminogen activator is effective in few patients when administered within 4.5 h after symptom onset. Hemorrhage transformation (HT) is a major cause of poor prognosis of AIS patients post intravenous rt-PA. Several studies report that high-density lipoprotein (HDL) cholesterol is associated with increased risk of HT. However, various studies report inconsistent results.

Objective: The aim of the present study was to explore the association between HDL and HT after treatment of AIS patients by intravenous thrombolysis.

Methods: A literature search for studies on the relationship between HDL and HT after treatment of AIS by intravenous thrombolysis published before, 28 Mar 2022, was conducted in PubMed, EMBASE, Cochrane, Web of Science, CNKI, CPVIP, Wan fang and SINOMED databases. Fixed effects model was used to estimate the mean differences (MDs) at 95% confidence interval (CI). Heterogeneity was assessed by Cochran's Q statistic and quantified by the I2 statistic. Analysis of included studies was carried out using Review Manager 5.4 and the publication bias was evaluated using Stata 16.0.

Results: A total of 445 studies were screened and 9 studies met the inclusion criteria and were included in this meta-analysis (n = 3673). The results showed that AIS patients with HT had significantly higher HDL concentrations compared with the AIS patients without HT (pooled mean difference, 0.05; 95% confidence interval (CI), 0.01-0.09; P = 0.008).

Conclusion: The findings showed that HDL was associated with HT after treatment of AIS by intravenous thrombolysis, implying that is a potential predictor of the risk of HT.

Keywords: High-density lipoprotein; Intravenous thrombolysis; Ischemic stroke; Meta-analysis.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Brain Ischemia* / complications
  • Brain Ischemia* / drug therapy
  • Cerebral Hemorrhage / etiology
  • Cholesterol, HDL
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Ischemic Stroke* / complications
  • Ischemic Stroke* / drug therapy
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / methods
  • Tissue Plasminogen Activator / adverse effects

Substances

  • Cholesterol, HDL
  • Fibrinolytic Agents
  • Tissue Plasminogen Activator